ES422172A1 - Nutrient media - Google Patents
Nutrient mediaInfo
- Publication number
- ES422172A1 ES422172A1 ES422172A ES422172A ES422172A1 ES 422172 A1 ES422172 A1 ES 422172A1 ES 422172 A ES422172 A ES 422172A ES 422172 A ES422172 A ES 422172A ES 422172 A1 ES422172 A1 ES 422172A1
- Authority
- ES
- Spain
- Prior art keywords
- sodium
- germs
- urinary tract
- chloride
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedure for the determination of therapeutic substances for the treatment of urinary tract infections, characterized in that a synthetic nutrient medium for microorganisms, especially for pathogenic germs of urinary tract infections, consisting essentially of approximately 0.25 to 1 g of L-arginine, 0.5-2 g of L-asparaginic acid (aspartic), 0.25-1 g of L-cysteine, 1-4 g of L-glutamic acid, 0.1-0.4 g of glycine, 0.15-0.6 g of L-histidine, 0.4-1.6 g of L-leucine, 0.25-1 g of L-isoleucine, 0.3-1.2 g of L -lisin, 0.15-0.6 g of L-methionine, 0.15-0.6 g of L-phenyl-alanine, 0.2-0.8 g of L-proline, 0.2-0, 8 g of L-threonine, 0.05-0.2 g of tryptophan, 0.2-0.8 g of L-tyrosine, 0.5-2 g of L-valine, 1.5-6 g of chloride sodium, 0.15-0.6 g of potassium chloride, 0.5-2 g of anhydrous sodium acetate, 0.5-2 g of sodium pyruvate, 3-12 g of sodium glycerophosphate pentahydrate, 0.025 -0.1 g of magnesium sulfate heptahydrate, 0.005-0.02 g of adenine, 0.0 05-0.02 g guanine, 0.005-0.02 g uracil, 1-4 g D-glucose, 0.005-0.02 g inosite, 0.005-0.02 g choline chloride, 0.005-0, 02 g of nicotinic acid amide, 0.005-0.02 g of thiamine hydrochloride, 0.0005-0.002 g of riboflavin, 0.003-0.012 g of pyridoxine hydrochloride, 0.005-0.02 g of calcium pantothenate, 0.005 -0.02 g of folic acid, 0.0001-0.0004 g of biotin, 0.0025-0.01 g of p-nitrophenyl-propanetriol, 0.05-0.2 g of pimaricin per liter of water, as well as a quantity of sodium hydroxide, in dilute aqueous solution, necessary for adjusting the pH to 7.2, and possibly a quantity of agar free of inhibiting substances necessary for the solidification of the nutrient medium, after sowing with the germs a certain amount of urine and to place circular sheets of paper that have been loaded with a certain amount in each case of a therapeutic substance for urinary tract, are incubated for 16 to 24 hours at 35 to 37ºC, and then c Based on the diameter of the inhibition halos formed taking into account the density of germs, the therapeutic substances that have a bactericidal, or at least bacteriostatic effect, are established against the pathogenic germ (s) to be combated. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2301211A DE2301211C3 (en) | 1973-01-11 | 1973-01-11 | Synthetic nutrient medium for microorganisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES422172A1 true ES422172A1 (en) | 1976-07-01 |
Family
ID=5868750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES422172A Expired ES422172A1 (en) | 1973-01-11 | 1974-01-10 | Nutrient media |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5046883A (en) |
| AT (1) | AT328087B (en) |
| BE (1) | BE809618A (en) |
| CA (1) | CA1032096A (en) |
| CH (1) | CH596303A5 (en) |
| DE (1) | DE2301211C3 (en) |
| DK (1) | DK141634C (en) |
| ES (1) | ES422172A1 (en) |
| FR (1) | FR2324733A1 (en) |
| GB (1) | GB1442715A (en) |
| IE (1) | IE39011B1 (en) |
| IL (1) | IL43988A (en) |
| IT (1) | IT1002615B (en) |
| LU (1) | LU69132A1 (en) |
| NL (1) | NL7400336A (en) |
| SE (1) | SE396405B (en) |
| ZA (1) | ZA74173B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2047739A (en) * | 1979-04-27 | 1980-12-03 | Roche Products Ltd | Nutrient medium |
| DE3238819A1 (en) * | 1982-10-20 | 1984-04-26 | Institut Virion AG, 8803 Rüschlikon | ADDITIONAL SOURCES FOR BREEDING CAMPYLOBACTER JEJUNI |
| GB9108066D0 (en) * | 1991-04-16 | 1991-06-05 | Amersham Int Plc | Method and apparatus for forming an array of biological particles |
| EP1584680A1 (en) * | 2004-04-08 | 2005-10-12 | Boehringer Ingelheim Austria GmbH | Fed-batch fermentation process for the production of plasmid DNA |
-
1973
- 1973-01-11 DE DE2301211A patent/DE2301211C3/en not_active Expired
-
1974
- 1974-01-02 AT AT774*BA patent/AT328087B/en not_active IP Right Cessation
- 1974-01-09 LU LU69132A patent/LU69132A1/xx unknown
- 1974-01-09 IT IT47611/74A patent/IT1002615B/en active
- 1974-01-09 CH CH24274A patent/CH596303A5/xx not_active IP Right Cessation
- 1974-01-10 NL NL7400336A patent/NL7400336A/xx not_active Application Discontinuation
- 1974-01-10 SE SE7400316A patent/SE396405B/en unknown
- 1974-01-10 DK DK12874A patent/DK141634C/en active
- 1974-01-10 ES ES422172A patent/ES422172A1/en not_active Expired
- 1974-01-10 IL IL43988A patent/IL43988A/en unknown
- 1974-01-10 BE BE139708A patent/BE809618A/en unknown
- 1974-01-10 CA CA189,865A patent/CA1032096A/en not_active Expired
- 1974-01-10 ZA ZA00740173A patent/ZA74173B/en unknown
- 1974-01-10 JP JP49006325A patent/JPS5046883A/ja active Pending
- 1974-01-11 IE IE00071/74A patent/IE39011B1/en unknown
- 1974-01-11 GB GB145674A patent/GB1442715A/en not_active Expired
- 1974-01-11 FR FR7401028A patent/FR2324733A1/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DK141634C (en) | 1980-10-13 |
| DE2301211A1 (en) | 1975-04-10 |
| AT328087B (en) | 1976-03-10 |
| DK141634B (en) | 1980-05-12 |
| IL43988A0 (en) | 1974-05-16 |
| FR2324733B1 (en) | 1978-02-10 |
| IT1002615B (en) | 1976-05-20 |
| DE2301211C3 (en) | 1978-06-22 |
| NL7400336A (en) | 1974-07-15 |
| IL43988A (en) | 1976-12-31 |
| CA1032096A (en) | 1978-05-30 |
| JPS5046883A (en) | 1975-04-25 |
| DE2301211B2 (en) | 1977-10-27 |
| ATA774A (en) | 1975-05-15 |
| FR2324733A1 (en) | 1977-04-15 |
| GB1442715A (en) | 1976-07-14 |
| IE39011B1 (en) | 1978-07-19 |
| SE396405B (en) | 1977-09-19 |
| AU6439174A (en) | 1975-07-10 |
| BE809618A (en) | 1974-07-10 |
| IE39011L (en) | 1974-07-11 |
| LU69132A1 (en) | 1975-12-09 |
| ZA74173B (en) | 1975-09-24 |
| CH596303A5 (en) | 1978-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Griffith et al. | Urease: Principal cause of infection stones | |
| JPS61243023A (en) | Anticollagenic non-antibacterial tetracycline composition, preparation and use | |
| NZ216907A (en) | Treatment of mycoplasmotic and bacterial infections in fowl | |
| MY131468A (en) | Method for producing l-glutamic acid | |
| WO2021077662A1 (en) | Polyurethane biofilm and method for high-density seedling and breeding of litopenaeus vannamei | |
| ES422172A1 (en) | Nutrient media | |
| WO2007099302A3 (en) | Methods of maintaining oral health in animals using morpholine derivatives | |
| WO2021057552A1 (en) | Fish farming apparatus provided with magnetizer and method for accelerating normal propagation and growth speed of fish | |
| CN105087460A (en) | ST cell culture medium | |
| JPS6224073B2 (en) | ||
| ES8601306A1 (en) | Fermentation process for the preparation of aconitic acid. | |
| GR3034120T3 (en) | Synthesis of homochiral 2-hydroxy acids. | |
| CN110878325A (en) | Optimized glutamic acid fermentation medium | |
| CN110885865A (en) | Method for producing α -type glutamic acid by fermentation | |
| SE8105746L (en) | FERMENTATIVE PREPARATION OF L-ISOLEUCIN | |
| JPS5835080B2 (en) | Method for producing L-isoleucine by fermentation method | |
| JP2989257B2 (en) | Nitric acid bacteria culture solution and high concentration culture method of the same | |
| JP2902148B2 (en) | Method for accelerating nitrification reaction of nitrate bacteria | |
| Branch | ACTIVITY OF ASPARTATE CARBAMOYLTRANSFERASE, ALANINE AND ASPARTATE AMINOTRANSFERASES IN LOACH EMBRYOS AFTER INCUBATION OF ZYGOTES IN SOLUTIONS OF BIOORGANIC COMPOUNDS | |
| RU2000110433A (en) | METHOD FOR MODELING INFARCTOID CARDIOVASOPATHY IN RATS | |
| Ransmeier et al. | Effect of Sulfur-Containing Compounds on Growth and Hydrogen Sulfide Production by Bacterium tularense. | |
| JPH0313874B2 (en) | ||
| RU2003107027A (en) | METHOD FOR SANITATION OF OBJECTS OF VETNADZOR INCUBATORY DRUG "BROKARSEPT" | |
| JPS63202377A (en) | Novel cell strain | |
| JPH026517B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19880218 |